Skip to main content
Clinical Trials/JPRN-UMIN000039580
JPRN-UMIN000039580
Recruiting
未知

The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis - The efficacy of HCV clearance

Chiba University Graduate School of Medicine0 sites20 target enrollmentFebruary 24, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
HCV-related cirrhosis
Sponsor
Chiba University Graduate School of Medicine
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2020
End Date
October 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chiba University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Antiviral therapy for HCV using direct acting antiviral drugs in patients with chronic hepatitis C undergoing hemodialysis.Patients with HCV genotype 1B infection who are undergoing maintenance hemodialysis.
JPRN-UMIN000017023Ogaki Municipal Hospital150
Active, not recruiting
Phase 1
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
Active, not recruiting
Phase 1
treatment of eradication of HCV infection in immigrant patients with innovative drugChronic HCV hepatitis, all fibrosisMedDRA version: 20.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10019755Term: Hepatitis chronic activeSystem Organ Class: 10019805 - Hepatobiliary disordersTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2017-001024-21-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli6,000
Recruiting
Not Applicable
The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan 10 day regime
JPRN-UMIN000022236Keio University School of Medicine100
Recruiting
Not Applicable
The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan regime
JPRN-jRCTs031180412Hirata Kenro100